GPR35 and metabolic dysfunction-associated steatotic liver disease: Our findings enhance our understanding of how GPR35 influences metabolite and lipid profiles in different liver regions and open new avenues for investigating the intricate molecular mechanisms underlying MASLD pathogenesis.